Curaleaf Holdings (CURLF) Assets Average (2020 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Assets Average of $3.0 billion for Q4 2024, down 4.72% year-on-year from $3.2 billion in Q1 2024, and down 2.16% on a QoQ basis from $3.1 billion in Q3 2024.

Curaleaf Holdings (CURLF) Assets Average (2020 - 2024) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Assets Average for 5 consecutive years, with $3.0 billion the latest figure, recorded in Q4 2024.

  • Quarterly Assets Average fell 4.72% year-over-year to $3.0 billion in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $3.0 billion (down 4.72% YoY) and the FY2025 annual result came in at $2.9 billion, down 4.16% from the prior year.
  • Assets Average retreated to $3.0 billion in Q4 2024 per CURLF's latest filing, from $3.1 billion in the prior quarter.
  • Over the last five years, Assets Average for CURLF reached as high as $3.3 billion in Q3 2023 and fell as low as $737.0 million in Q3 2022.
  • A 5-year average of $2.4 billion and a median of $2.4 billion in 2020 frame the typical range for Assets Average.
  • Annual changes were most pronounced in 2022 — Assets Average plunged 76.71% — and 2023, when it soared 342.99%.
  • Year by year, Assets Average stood at $2.4 billion in 2020, then dropped by 17.2% to $2.0 billion in 2021, then advanced by 6.13% to $2.1 billion in 2022, then jumped by 52.3% to $3.2 billion in 2023, then declined by 4.72% to $3.0 billion in 2024.
  • According to Business Quant data, Assets Average over the past three periods registered $3.0 billion, $3.1 billion, and $3.2 billion for Q4 2024, Q3 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.72 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.39 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.32 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 99.52 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 7.30 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 68.63 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 37.01 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.77 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.29 Bn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 3.01 Bn
Sep 30, 2024 3.08 Bn
Dec 31, 2023 3.16 Bn
Sep 30, 2023 3.26 Bn
Jun 30, 2023 2.02 Bn
Mar 31, 2023 2.08 Bn
Dec 31, 2022 2.08 Bn
Sep 30, 2022 737.03 Mn
Jun 30, 2022 2.14 Bn
Mar 31, 2022 2.14 Bn
Dec 31, 2021 1.96 Bn
Sep 30, 2021 3.16 Bn
Jun 30, 2021 2.92 Bn
Mar 31, 2021 2.52 Bn
Dec 31, 2020 2.36 Bn